Construction of lignan glycosides biosynthetic network in Escherichia coli using mutltienzyme modules

• Published in: Microbial cell factories Vol. 23; no. 1; pp. 193 - 14
• Main Authors: Qiao, Yuqi, Huang, Doudou, Li, Yajing, Jiang, Songfan, Chen, Xiao, Chen, Junfeng, Xiao, Ying, Chen, Wansheng
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 05.07.2024; BioMed Central; BMC
• Subjects: Biosynthetic Pathways; Chemical engineering; Chemical engineering research; Chemical properties; Escherichia coli; Escherichia coli - genetics; Escherichia coli - metabolism; Fermentation; Furans - metabolism; Genetic aspects; Glycosides; Glycosides - biosynthesis; Glycosides - metabolism; Heterologous biosynthesis; Lignans; Lignans - biosynthesis; Lignans - metabolism; Metabolic engineering; Metabolic Engineering - methods; Methods; Microbiological synthesis; Module assembly; Physiological aspects; Production processes; Synthetic Biology - methods; China; Module assembly; Escherichia coli; Lignans; Heterologous biosynthesis
• ISSN: 1475-2859; 1475-2859
• DOI: 10.1186/s12934-024-02467-1

Due to the complexity of the metabolic pathway network of active ingredients, precise targeted synthesis of any active ingredient on a synthetic network is a huge challenge. Based on a complete analysis of the active ingredient pathway in a species, this goal can be achieved by elucidating the functional differences of each enzyme in the pathway and achieving this goal through different combinations. Lignans are a class of phytoestrogens that are present abundantly in plants and play a role in various physiological activities of plants due to their structural diversity. In addition, lignans offer various medicinal benefits to humans. Despite their value, the low concentration of lignans in plants limits their extraction and utilization. Recently, synthetic biology approaches have been explored for lignan production, but achieving the synthesis of most lignans, especially the more valuable lignan glycosides, across the entire synthetic network remains incomplete. By evaluating various gene construction methods and sequences, we determined that the pCDF-Duet-Prx02-PsVAO gene construction was the most effective for the production of (+)-pinoresinol, yielding up to 698.9 mg/L after shake-flask fermentation. Based on the stable production of (+)-pinoresinol, we synthesized downstream metabolites in vivo. By comparing different fermentation methods, including "one-cell, one-pot" and "multicellular one-pot", we determined that the "multicellular one-pot" method was more effective for producing (+)-lariciresinol, (-)-secoisolariciresinol, (-)-matairesinol, and their glycoside products. The "multicellular one-pot" fermentation yielded 434.08 mg/L of (+)-lariciresinol, 96.81 mg/L of (-)-secoisolariciresinol, and 45.14 mg/L of (-)-matairesinol. Subsequently, ultilizing the strict substrate recognition pecificities of UDP-glycosyltransferase (UGT) incorporating the native uridine diphosphate glucose (UDPG) Module for in vivo synthesis of glycoside products resulted in the following yields: (+)-pinoresinol glucoside: 1.71 mg/L, (+)-lariciresinol-4-O-D-glucopyranoside: 1.3 mg/L, (+)-lariciresinol-4'-O-D-glucopyranoside: 836 µg/L, (-)-secoisolariciresinol monoglucoside: 103.77 µg/L, (-)-matairesinol-4-O-D-glucopyranoside: 86.79 µg/L, and (-)-matairesinol-4'-O-D-glucopyranoside: 74.5 µg/L. By using various construction and fermentation methods, we successfully synthesized 10 products of the lignan pathway in Isatis indigotica Fort in Escherichia coli, with eugenol as substrate. Additionally, we obtained a diverse range of lignan products by combining different modules, setting a foundation for future high-yield lignan production.